Transforming Health.
Together.
MEPTIDE (Tirzepatide) is an advanced once-weekly injectable therapy designed to support glycemic control and meaningful weight management through dual GIP and GLP-1 receptor activation.
A first-in-class dual receptor agonist
MEPTIDE contains Tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist developed for the management of Type 2 Diabetes Mellitus and Obesity/Overweight. It improves glycemic control while producing clinically meaningful and sustained weight reduction through complementary metabolic pathways.
First-in-Class
Dual GIP + GLP-1 receptor agonist
Once Weekly
Single-dose pre-filled pen autoinjector
Clinically Studied
Supported by SURPASS & SURMOUNT programs
Doctor Guided
Prescription medicine, always under care
Working with your body's natural hormones
Tirzepatide activates two naturally occurring hormones — GIP and GLP-1 — that work together to reduce appetite, control hunger, improve blood sugar regulation, and support long-term weight management.
Tirzepatide Injection
Once-weekly subcutaneous injection
GIP Activation
Amplifies insulin secretion
GLP-1 Activation
Reduces glucagon & appetite
Improved Glucose Control
Lower HbA1c, stable sugars
Reduced Appetite
Greater satiety, fewer cravings
Weight Management
Meaningful, sustained reduction
Benefits patients may experience
From improved glucose control to significant weight reduction, MEPTIDE supports meaningful, sustained health improvements. Individual results vary.
Glycemic Control
Significant HbA1c reduction with improved fasting and post-meal glucose control through dual receptor activation.
Significant Weight Loss
Clinically meaningful and sustained body weight reduction across the treatment journey, as demonstrated in clinical trials.
Appetite Control
Reduced appetite and increased satiety help lower caloric intake and support healthier eating patterns.
Cardiometabolic Benefits
Improved blood pressure, lipid profile, and waist circumference support overall cardiometabolic health.
Better Beta Cell Function
Enhances pancreatic beta-cell function and insulin sensitivity, supporting long-term metabolic health.
Patient Satisfaction
Once-weekly administration promotes treatment adherence and improved quality of life.
Choose the dose that fits your treatment journey
MEPTIDE is available in four strengths. Your healthcare provider will determine the right dose and escalation schedule for you.
Starter DoseMEPTIDE 2.5mg
/0.5ml • Once Weekly
The starting dose of MEPTIDE. Weeks 1-4 of therapy, designed to introduce the body to Tirzepatide and build tolerability.
- Pre-filled single-dose pen
- Administer once weekly
- Subcutaneous injection
15% OFF on Online Orders
Step ForwardMEPTIDE 5mg
/0.5ml • Once Weekly
The next step in the treatment journey. Weeks 5-8, providing enhanced glycemic control and continued weight management.
- Pre-filled single-dose pen
- Administer once weekly
- Subcutaneous injection
15% OFF on Online Orders
Treatment ProgressMEPTIDE 7.5mg
/0.5ml • Once Weekly
Weeks 9-12. A higher maintenance dose for patients requiring additional glycemic and weight control when clinically indicated.
- Pre-filled single-dose pen
- Administer once weekly
- Subcutaneous injection
15% OFF on Online Orders
Maximum SupportMEPTIDE 10mg
/0.5ml • Once Weekly
Week 13 onward. The maximum maintenance dose for patients who need the strongest effect, if clinically indicated.
- Pre-filled single-dose pen
- Administer once weekly
- Subcutaneous injection
15% OFF on Online Orders
A premium pre-filled pen designed for you
The MEPTIDE Quick Pen is a single-dose, disposable pre-filled autoinjector. The needle is hidden, so you do not have to see or handle it. Simply press and hold — the pen does the rest.
Hidden needle
No need to see or handle the needle — safer and more comfortable.
Press and hold
Listen for the click and hold for approximately 10-15 seconds.
Clear dose window
You'll know the injection is complete when the plunger covers the window.
Disposable
Reattach the cap and dispose of the used pen safely.
Your weight management journey
Weight management is a journey — not a race. With medical guidance, healthy lifestyle changes, and commitment, lasting weight loss is achievable.
Month 1
Early Changes
Appetite begins to decrease and patients start to adapt to the once-weekly routine. The body adjusts to the starting dose.
Month 2-3
Progress
Steady weight reduction begins as the dose steps up. Blood sugar regulation and appetite control continue to improve.
Month 4-6
Continued Improvement
Continued improvements in weight, metabolic markers, and overall wellbeing are observed with consistent treatment and lifestyle changes.
Beyond 6 Months
Long-Term Management
Long-term weight management with continued treatment, healthy eating, physical activity, and regular medical follow-up. Consistency matters.
Learn more with the Mass Endocrine Academy
Explore educational videos, tutorials and patient resources to better understand MEPTIDE, weight management and your treatment journey.
Take the First Step Toward a Healthier Future
MEPTIDE is a prescription medicine. Talk to your doctor to determine whether Tirzepatide is appropriate for your glycemic control and weight-management goals.
Individual results vary. Always follow your healthcare provider's guidance.